Rituximab: all 1,386 studies that test it

Page 6 of 14. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.

• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00541034Phase 2Results posted
• A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid SyndromeCompletedNCT00537290Phase 2Results posted
• Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT00536341Phase 1/2Results posted
• A Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.CompletedNCT00532129Phase 2Results posted
• CFAR Study in Patients With Chronic Lymphocytic LeukemiaCompletedNCT00525603Phase 2Results posted
• GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin LymphomaCompletedNCT00521014Phase 2Results posted
• A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma.TerminatedNCT00517699Phase 2Results posted
• Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaTerminatedNCT00513747Phase 3Results posted
• Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular LymphomaTerminatedNCT00510887Phase 2Results posted
• Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCLCompletedNCT00504751Phase 2Results posted
• Rituximab and ABVD for Hodgkin's PatientsCompletedNCT00504504Phase 2Results posted
• A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.CompletedNCT00503425Phase 3Results posted
• A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.CompletedNCT00502996Phase 3Results posted
• A Pilot Study of MabThera (Rituximab) Evaluated by MRI in Patients With Rheumatoid Arthritis.CompletedNCT00502853Phase 4Results posted
• A Study of Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.CompletedNCT00502840Phase 3Results posted
• Rituximab in Progressive Immunoglobulin A (IgA) NephropathyCompletedNCT00498368Phase 4Results posted
• Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanCompletedNCT00496873Phase 2Results posted
• Bortezomib and Rituximab for Patients With Waldenstrom's MacroglobulinemiaActive, not recruitingNCT00492050Phase 2Results posted
• Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's LymphomaTerminatedNCT00481832Phase 2Results posted
• Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell LymphomaCompletedNCT00477412Phase 1/2Results posted
• Thymoglobulin and Total Lymphoid Irradiation for Hematologic MalignanciesCompletedNCT00476229Not applicableResults posted
• A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.CompletedNCT00475423Phase 2Results posted
• Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and LeukemiasCompletedNCT00472849Phase 1/2Results posted
• A Study of MabThera (Rituximab) Plus Standard Chemotherapy in Patients With Previously Untreated Mantle Cell Lymphoma.CompletedNCT00472420Phase 2Results posted
• Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid MalignanciesCompletedNCT00472056Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha TherapyCompletedNCT00468546Phase 3Results posted
• A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.CompletedNCT00462345Phase 4Results posted
• Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's LymphomaCompletedNCT00460109Phase 2Results posted
• Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone LymphomaCompletedNCT00453102Phase 2Results posted
• Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLLCompletedNCT00452374Phase 1/2Results posted
• R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell LymphomaCompletedNCT00450801Phase 2Results posted
• Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP)TerminatedNCT00450385Phase 2Results posted
• FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)CompletedNCT00448019Phase 2Results posted
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal TransplantCompletedNCT00446251Phase 2Results posted
• The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)CompletedNCT00444912Phase 2Results posted
• A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid ArthritisCompletedNCT00443651Phase 3Results posted
• Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaCompletedNCT00438880Phase 1/2Results posted
• Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic LeukemiaCompletedNCT00436904Phase 2Results posted
• Chemotherapy for Participants With LymphomaCompletedNCT00436280Phase 2Results posted
• MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.CompletedNCT00430352Phase 4Results posted
• Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic LeukemiaCompletedNCT00427791Phase 2Results posted
• Cellular Therapy With Cord Blood CellsCompletedNCT00427557Phase 2Results posted
• Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00425802Phase 2Results posted
• Rituxan in Churg Strauss Syndrome With Renal InvolvementTerminatedNCT00424749Phase 2Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.CompletedNCT00424502Phase 4Results posted
• Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)CompletedNCT00422799Phase 2Results posted
• A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)CompletedNCT00422383Phase 3Results posted
• Rituximab in the Treatment of Scleritis and Non-Infectious Orbital InflammationCompletedNCT00415506Phase 1/2Results posted
• VELCADE,Rituximab,Cyclophosphamide and DecadronTerminatedNCT00413959Phase 2Results posted
• Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell LymphomaCompletedNCT00411086Phase 2Results posted
• Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell LymphomaCompletedNCT00401817Phase 2Results posted
• A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's LymphomasTerminatedNCT00400764Phase 1/2Results posted
• Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)TerminatedNCT00396812Phase 1/2Results posted
• Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like LymphomaCompletedNCT00392990Phase 2Results posted
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's LymphomaCompletedNCT00389818Phase 2Results posted
• Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's LymphomaCompletedNCT00387959Phase 2Results posted
• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus ErythematosusTerminatedNCT00381810Phase 3Results posted
• FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic LeukemiaCompletedNCT00381004Phase 2Results posted
• Rituximab for Prevention of Chronic GVHDCompletedNCT00379587Phase 1/2Results posted
• S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00376961Phase 2Results posted
• Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHLCompletedNCT00369707Phase 2Results posted
• Phase 2 Study of Rituximab-ABVD in Classical Hodgkin LymphomaCompletedNCT00369681Phase 2Results posted
• Initial Study of Rituximab to Treat Primary Biliary CirrhosisCompletedNCT00364819Phase 1/2Results posted
• A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host DiseaseCompletedNCT00350545Not applicableResults posted
• Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System LymphomaTerminatedNCT00335140Phase 2Results posted
• Rituximab to Treat Severe Hemophilia ACompletedNCT00331006Phase 2Results posted
• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaCompletedNCT00312845Phase 3Results posted
• Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA AlloantibodiesCompletedNCT00307125Phase 2Results posted
• Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia ATerminatedNCT00306670Phase 2/3Results posted
• Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaCompletedNCT00301821Phase 2Results posted
• Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)CompletedNCT00299494Phase 1/2Results posted
• A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid ArthritisCompletedNCT00299130Phase 3Results posted
• A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid ArthritisCompletedNCT00299104Phase 3Results posted
• Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid ArthritisTerminatedNCT00298272Phase 2Results posted
• Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaCompletedNCT00295932Phase 1/2Results posted
• Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell LymphomaCompletedNCT00294632Phase 1/2Results posted
• Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular LymphomaCompletedNCT00290511Phase 2Results posted
• Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)TerminatedNCT00290407Phase 2Results posted
• Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaTerminatedNCT00288067Phase 1/2Results posted
• Rituximab in the Treatment of Patients With Bullous PemphigoidCompletedNCT00286325Phase 1/2Results posted
• A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus NephritisCompletedNCT00282347Phase 3Results posted
• A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background MethotrexateCompletedNCT00282308Phase 2Results posted
• Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic LeukemiaCompletedNCT00281918Phase 3Results posted
• Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00280241Phase 2Results posted
• Rituximab in New Onset Type 1 DiabetesCompletedNCT00279305Phase 2Results posted
• Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's LymphomaCompletedNCT00278161Phase 2Results posted
• A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's LymphomaCompletedNCT00269113Phase 3Results posted
• Chemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaCompletedNCT00267865Phase 2Results posted
• A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background MethotrexateCompletedNCT00266227Phase 3Results posted
• Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple MyelomaCompletedNCT00258206Phase 2Results posted
• FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 YearsCompletedNCT00254410Phase 2Results posted
• Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms MacroglobulinemiaCompletedNCT00250926Phase 2Results posted
• Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic ApproachTerminatedNCT00250718Phase 2Results posted
• Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's LymphomaTerminatedNCT00248534Phase 2Results posted
• Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00244985Phase 1/2Results posted
• Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin LymphomaCompletedNCT00244855Phase 2Results posted
• A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving MethotrexateCompletedNCT00243412Phase 2Results posted
• Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to RituximabCompletedNCT00238238Phase 2Results posted
• Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan AnemiaCompletedNCT00229619Phase 2Results posted
• Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's LymphomaCompletedNCT00225212Phase 2Results posted

← Rituximab overview